Medical Applications of Biologic Drugs
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biologics and Biosimilars".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 12
Special Issue Editors
Interests: natural products; antioxidants; phytochemicals; nutrivigilance; toxicology; dendrimers; drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: phytochemical analyses; antioxidants; polyphenols; environmental sciences; natural products; nutrivigilance; dendrimers; drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacovigilance; drug delivery; dendrimers; drug delivery systems; targeted drug delivery; formulation; natural products
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacology; drug safety; antimicrobial resistance; drug efficacy
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; analytical methods; biochemistry; laboratory tests; natural products; antioxidants; dendrimers; pharmacovigilance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Since the 1980s, biologic drugs have revolutionized disease management by offering distinct benefits in optimizing therapeutic outcomes and improving the quality of life. These smart delivery systems can provide a targeted delivery of drugs, an enhanced efficacy, and a lower risk of side effects. In the era of personalized medicine, the use of biologic drugs represents an innovative treatment, and is more and more spread in different therapeutic areas, from cancer therapy to regenerative medicine.
The purpose of this Special Issue is to collect papers that offer novel insights in the field of biologics such as chemical, pharmacological, and toxicological properties, technological processes, and therapeutical activity. Key areas include design, preparations and characterizations of biologics, drug delivery systems, drug delivery challenges, formulation, pharmacokinetics, biopharmaceuticals, drug release and action mechanisms, in vitro and in vivo studies regarding their effectiveness or toxicity, therapeutic and clinical evaluations, etc.
Authors are invited to send manuscripts including original research or literature reviews referring to biologic drugs used in different medical domains.
Dr. Carmen Maximiliana Dobrea
Dr. Adina Frum
Dr. Anca Butuca
Dr. Claudiu Morgovan
Prof. Dr. Felicia-Gabriela Gligor
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- monoclonal antibodies
- vaccines
- hormones
- biologic enzymes
- immunosuppressants
- immunomodulators
- biologic drug development
- mechanism of action
- safety and efficacy
- therapeutic outcomes
- biosimilars
- gene therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
